📰 Recommendation Statement News
Page 4 - Recommendation Statement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Recommendation Statement. Real-time updates on events, politics, business and more.
January 11, 2024
Extended Regulatory Review Certain Offer Continues to Undervalue Wyndham and Exposes Wyndham Shareholders to Significant Asymmetrical Risk PARSIPPANY, N.J., Jan. 11, 2024 /PRNewswire/ -- Wyndham...
January 1, 2024
ANNOUNCEMENT REGARDING RULE 15 PROPOSALS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION
January 1, 2024
/PRNewswire/ -- On 24 May 2024, Bidco and K1 announced that the offer document (the "Offer Document") in relation to Bidcos offer to acquire the entire issued...
December 22, 2023
CAMBRIDGE, Mass., Dec. 22, 2023 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery,...
December 22, 2023
Euronav to acquire CMB.TECH as part of its new strategy 22 Dec 2023 22:01 CET Subscribe ...
December 19, 2023
Wyndham Hotels & Resorts (NYSE: WH) (“Wyndham” or the “Company”), today announced that its Board of Directors, following a comprehensive review with its outside financial and legal advisors, has unanimously determined the unsolicited exchange offer (the “Offer”) from Choice Hotels International, Inc. (NYSE: CHH) (“Choice”) to acquire all outstanding shares of Wyndham is NOT in the best interests of Wyndham and its shareholders. The Wyndham Board of Directors unanimously recom...
December 18, 2023
Board Unanimously Recommends Wyndham Shareholders NOT Tender Shares Choice Ignores Significant Regulatory and Business Risks and Misleads Wyndham Shareholders and Other Stakeholders...
December 18, 2023
Phase 3 SPLASH study of 177Lu-PNT2002 demonstrated statistically significant improvement in radiographic progression-free survival BEDFORD, Mass., and INDIANAPOLIS, Dec. 18, 2023 -- December...
December 18, 2023
INDIANAPOLIS, Dec. 18, 2023 /PRNewswire/ -- Eli Lilly and Company today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding shares of common...
December 18, 2023
Phase 3 SPLASH study of177Lu-PNT2002 demonstrated statistically significant improvement in radiographic progression-free survival (rPFS)